Kim Y - Search Results

1

Radiosensitization of brain metastasis by targeting c-MET.

Yang H, Lee HW, Kim Y, Lee Y, Choi YS, Kim KH, Jin J, Lee J, Joo KM, Nam DH. Yang H, et al. Among authors: kim y, kim kh. Lab Invest. 2013 Mar;93(3):344-53. doi: 10.1038/labinvest.2012.180. Epub 2013 Feb 4. Lab Invest. 2013. PMID: 23381625 Free article.

2

Synergistic therapeutic effects of cytokine-induced killer cells and temozolomide against glioblastoma.

Jin J, Joo KM, Lee SJ, Jo MY, Kim Y, Jin Y, Kim JK, Ahn JM, Yoon MJ, Lim J, Nam DH. Jin J, et al. Among authors: kim jk, kim y. Oncol Rep. 2011 Jan;25(1):33-9. Oncol Rep. 2011. PMID: 21109954

3

Combined treatment of tumor-tropic human neural stem cells containing the CD suicide gene effectively targets brain tumors provoking a mild immune response.

Lee SJ, Kim Y, Jo MY, Kim HS, Jin Y, Kim SU, Jin J, Joo KM, Nam DH. Lee SJ, et al. Among authors: kim su, kim hs, kim y. Oncol Rep. 2011 Jan;25(1):63-8. Oncol Rep. 2011. PMID: 21109958

4

Time-course analysis of DNA damage response-related genes after in vitro radiation in H460 and H1229 lung cancer cell lines.

Kim KH, Yoo HY, Joo KM, Jung Y, Jin J, Kim Y, Yoon SJ, Choi SH, Seol HJ, Park WY, Nam DH. Kim KH, et al. Among authors: kim y. Exp Mol Med. 2011 Jul 30;43(7):419-26. doi: 10.3858/emm.2011.43.7.046. Exp Mol Med. 2011. PMID: 21633183 Free PMC article.

5

Genetically engineered human neural stem cells with rabbit carboxyl esterase can target brain metastasis from breast cancer.

Seol HJ, Jin J, Seong DH, Joo KM, Kang W, Yang H, Kim J, Shin CS, Kim Y, Kim KH, Kong DS, Lee JI, Aboody KS, Lee HJ, Kim SU, Nam DH. Seol HJ, et al. Among authors: kim su, kim j, kim y, kim kh. Cancer Lett. 2011 Dec 8;311(2):152-9. doi: 10.1016/j.canlet.2011.07.001. Epub 2011 Jul 14. Cancer Lett. 2011. PMID: 21868150

6

In vivo specific delivery of c-Met siRNA to glioblastoma using cationic solid lipid nanoparticles.

Jin J, Bae KH, Yang H, Lee SJ, Kim H, Kim Y, Joo KM, Seo SW, Park TG, Nam DH. Jin J, et al. Among authors: kim h, kim y. Bioconjug Chem. 2011 Dec 21;22(12):2568-72. doi: 10.1021/bc200406n. Epub 2011 Nov 28. Bioconjug Chem. 2011. PMID: 22070554

7

Wnt activation is implicated in glioblastoma radioresistance.

Kim Y, Kim KH, Lee J, Lee YA, Kim M, Lee SJ, Park K, Yang H, Jin J, Joo KM, Lee J, Nam DH. Kim Y, et al. Among authors: kim m, kim kh. Lab Invest. 2012 Mar;92(3):466-73. doi: 10.1038/labinvest.2011.161. Epub 2011 Nov 14. Lab Invest. 2012. PMID: 22083670 Free article.

8

Identification of prognostic biomarkers for glioblastomas using protein expression profiling.

Jung Y, Joo KM, Seong DH, Choi YL, Kong DS, Kim Y, Kim MH, Jin J, Suh YL, Seol HJ, Shin CS, Lee JI, Kim JH, Song SY, Nam DH. Jung Y, et al. Among authors: kim mh, kim y, kim jh. Int J Oncol. 2012 Apr;40(4):1122-32. doi: 10.3892/ijo.2011.1302. Epub 2011 Dec 15. Int J Oncol. 2012. PMID: 22179774 Free PMC article.

9

The expression of DNA damage checkpoint proteins and prognostic implication in metastatic brain tumors.

Seol HJ, Yoo HY, Jin J, Joo KM, Kim HS, Yoon SJ, Choi SH, Kim Y, Pyo HR, Lim DH, Kim W, Um HD, Kim JH, Lee JI, Nam DH. Seol HJ, et al. Among authors: kim w, kim hs, kim y, kim jh. Oncol Res. 2011;19(8-9):381-90. doi: 10.3727/096504011x13123323849654. Oncol Res. 2011. PMID: 22329197

10

Combined therapy of temozolomide and ZD6474 (vandetanib) effectively reduces glioblastoma tumor volume through anti-angiogenic and anti-proliferative mechanisms.

Jo MY, Kim YG, Kim Y, Lee SJ, Kim MH, Joo KM, Kim HH, Nam DH. Jo MY, et al. Among authors: kim hh, kim mh, kim y, kim yg. Mol Med Rep. 2012 Jul;6(1):88-92. doi: 10.3892/mmr.2012.868. Epub 2012 Apr 11. Mol Med Rep. 2012. PMID: 22505191

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

85,825 results

Search Page

Filters